We’re learning from things that went wrong
We’re learning from things that went wrong.
When the drug solanezumab failed to show benefits for people with dementia, we brought together the scientists who made the drug and international experts to discuss what lessons we can learn for future dementia research.
If set-backs happen, we’ll continue to take every opportunity to make our next step forward even bigger.